Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1)

Clinical trial NCT03870945 · COMPLETED

Trial details

NCT number: NCT03870945
Sponsor: Miltenyi Biomedicine GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma

Start date: 2019-02-25
Primary completion: 2020-12-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.